Objective To monitor the development process in diabetic retinopathy (DR) by color Doppler imaging (CDI), retinal vessel digest preparations, and histopathology, and to investigate the relationship between the hemodynamic changes of retina and retinal vessel morphology in diabetic rats. Methods Diabetic rats were induced by ip administration of Streptozotocin. The hemodynamic changes of central retina artery (CRA) of the right eyes of rats in the model group and control group were detected with CDI in diabetic duration of 2, 4, and 6 months, respectively. The right eyes of rats were dissected to make retinal vessel digest preparations to calculate endotheliocyte/perithelial cell ratio, the left eyes of rats were dissected for histopathology tests. Results There was significant difference of CRA hemodynamics between diabetic and normal rats in diabetic duration of two months. In contrast, the loss of pericapillary cells and hyperplasia endothelial as the only early changes of DR were demonstrated in 4 and 6 months diabetic rats in retinal digest preparations. Under the light microscope, the neovascularization, haemorrhage, and effusion in retina interior were observed at this time. Conclusion The results show that the retinal hemodynamics could display abnormal changes and become more serious with the progress of the disease, and suggest that the reduction of retinal blood flow and blood dabbling be important causes of DR in the early stage of diabetes. In the early stage of diabetes, corresponding treatment should be taken before the onset of DR to improve blood supply of the retina, which may postpone or reverse the incidence and development of DR."/>

醉酒后少妇被疯狂内射视频,一本色道久久综合一,在线天堂新版资源www在线下载,中文字幕乱人伦高清视频,中字幕视频在线永久在线观看免费

首頁(yè) > 過(guò)刊瀏覽>2011年第34卷第3期 >2011,34(3):167-170. DOI:10.7501/j.issn.0253-6376.[year].3.[sequence]
上一篇 | 下一篇

糖尿病大鼠視網(wǎng)膜血流動(dòng)力學(xué)與視網(wǎng)膜血管形態(tài)學(xué)關(guān)系的研究

Relationship between hemodynamic changes of retina and morphology of retinal vessel in diabetic rats

發(fā)布日期:
您是第位訪問(wèn)者
藥物評(píng)價(jià)研究 ® 2025 版權(quán)所有
技術(shù)支持:北京勤云科技發(fā)展有限公司
津備案:津ICP備13000267號(hào) 互聯(lián)網(wǎng)藥品信息服務(wù)資格證書(shū)編號(hào):(津)-非經(jīng)營(yíng)性-2015-0031